• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Brazil's Anvisa suspends Covaxin shot's emergency use application

firstwordpharmaJuly 01, 2021

Tag: brazil , Covaxin , COVID-19 , Vaccine

Brazil's health regulator has suspended Covaxin's emergency-use application, which was filed by an intermediary on behalf of the COVID-19 vaccine's developer Bharat Biotech, as reported in This is Money.

Brazil's Anvisa suspends Covaxin shot's emergency use application

Anvisa said the intermediary, Precisa, did not submit, or only partially submitted, mandatory and essential documents for the vaccine.

Covaxin has become highly controversial in Brazil over allegations of "irregularities" in the government's efforts to buy 20 million doses.

Previous:Letting children catch Covid may be safer than giving them vaccine, say experts

Next:Tenaya Therapeutics Announces New Appointments to Leadership Team

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Brazil's Anvisa suspends Covaxin shot's emergency use application | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Poultry Vaccine Series 2

Poultry Vaccine Series 2
Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production

Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production
Hepatitis A (Live) Vaccine, Freeze-Dried

Hepatitis A (Live) Vaccine, Freeze-Dried
Pet Vaccine Series

Pet Vaccine Series
Animal Vaccine Filling Line

Animal Vaccine Filling Line
Poliomyelitis Vaccine Type I Type III in Dragee Candy (Human Diploid Cell), Live

Poliomyelitis Vaccine Type I Type III in Dragee Candy (Human Diploid Cell), Live
Acai Berry Extract，Brazil Berry Extract

Acai Berry Extract，Brazil Berry Extract
Swine Vaccine Series

Swine Vaccine Series
Brazilin

Brazilin
SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)

SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service